Lv57
1398 积分 2024-02-23 加入
Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx
4天前
已完结
Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
8天前
已完结
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
8天前
已完结
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectiveness
8天前
已完结
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectiveness
9天前
已关闭
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma
9天前
已完结
Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting Glypican 3 effectively control human hepatocellular carcinoma in mice
9天前
已完结
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation
9天前
已完结
Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial
9天前
已完结
Chimeric Antigen Receptor (CAR) T-cell Therapy: Engineering Immune Cells To Treat Liver Diseases
9天前
已完结
皖公网安备34019202002308
